Jenkins Abigail L. 4
4 · Aquestive Therapeutics, Inc. · Filed May 13, 2024
Insider Transaction Report
Form 4
Jenkins Abigail L.
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-05-10−57,000→ 57,000 totalExercise: $3.09Exp: 2034-05-10→ Common Stock (57,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments beginning on May 10, 2025.